Study highlights risks of stopping anticoagulants in older patients
For patients with atrial fibrillation, the risk of stroke or heart attack from stopping anticoagulants usually outweighs the risk of bleeding, according to new findings from the University of Bath.
Press Release: Dupixent sBLA accepted for FDA priority review for the targeted treatment of bullous pemphigoid
Dupixent sBLA accepted for FDA priority review for the targeted treatment of bullous pemphigoidIf approved, Dupixent would be the first and only ...
Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for the Targeted Treatment of Bullous Pemphigoid (BP)
If approved, Dupixent would be the first and only targeted medicine to treat BP in the U.S.; FDA decision expected by June 20, 2025Priority ...
Chemistry World14h
Apothecary inventory offers glimpse into medicines from the 17th century
Catalogue of shop in Nantwich, Cheshire reveals 'treatments' using everything from quicksilver and arsenic to 'oil of ...
Becker's Hospital Review4h
UNC Health hospital taps COO
Meet the new COO of UNC Health Nash, Rebecca Hutton Schulkowski, PharmD, bringing two decades of experience to the role. Learn more about her appointment and U ...